Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	7/9/2004 11:35:47 AM
From: nigel bates	of 625

-- Worldwide HUMIRA sales were $203 million in the second quarter, including $65 million in international sales, exceeding company forecasts. Based on the performance of HUMIRA in the first half of this year, Abbott is raising its full-year 2004 worldwide sales estimate for HUMIRA from more than $700 million to more than $800 million. Roll on November...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next